Conventional markers, such as prostate-specific antigen (PSA), carbohydrate antigen 199 (CA199), and alpha-fetoprotein (AFP) are useful for screening prostate carcinoma, pancreatic carcinoma, and hepatic carcinoma, respectively (Sturgeon, 2002). This evidence concerns the gene AFP and exocrine pancreatic carcinoma.